These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8915566)

  • 1. Neurological soft signs and response to risperidone in chronic schizophrenia.
    Smith RC; Kadewari RP
    Biol Psychiatry; 1996 Nov; 40(10):1056-9. PubMed ID: 8915566
    [No Abstract]   [Full Text] [Related]  

  • 2. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
    Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
    Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S; Gerami M; Noroozian M; Karamghadiri N; Ghoreishi A; Abbasi SH; Rezazadeh SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1810-5. PubMed ID: 18727948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reemergence of positive symptoms after initial response to risperidone.
    Cung DD; Stimmel GL
    Pharmacotherapy; 1997; 17(2):383-6. PubMed ID: 9085334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggression and schizophrenia: efficacy of risperidone.
    Buckley PF; Ibrahim ZY; Singer B; Orr B; Donenwirth K; Brar PS
    J Am Acad Psychiatry Law; 1997; 25(2):173-81. PubMed ID: 9213289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
    López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
    Ruhrmann S; Kissling W; Lesch OM; Schmauss M; Seemann U; Philipp M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1012-22. PubMed ID: 17412473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-risperidone combination in treatment-resistant schizophrenia.
    Raju ; Kumar R; Khanna S
    Aust N Z J Psychiatry; 2001 Aug; 35(4):543. PubMed ID: 11531741
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study.
    Dursun SM; Patel JK; Burke JG; Reveley MA
    J Psychiatry Neurosci; 1999 Sep; 24(4):333-7. PubMed ID: 10516800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The change: subjective perception of patients treated by risperidone].
    Llorca PM
    Encephale; 2002; 28 Spec No 2 Pt 2():S29-30. PubMed ID: 12587354
    [No Abstract]   [Full Text] [Related]  

  • 11. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria.
    Gómez-Perretta C
    Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rispolept (risperidone) efficacy in the treatment of patients with schizophrenia and psychoactive drug dependence].
    Drozdov ES
    Voen Med Zh; 2002 Jul; 323(7):46-52. PubMed ID: 12192989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuroleptic treatment and neurological soft signs in schizophrenic patients].
    Mechri A; Slama H; Chebel S; Mandhouj O; Gaha L
    Therapie; 2007; 62(5):449-53. PubMed ID: 18206107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risperidone and edema: apropos of a case].
    Masson M; Elayli R; Verdoux H
    Encephale; 2000; 26(3):91-2. PubMed ID: 10951912
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishing a dose-response relationship for oral risperidone in relapsed schizophrenia.
    Ezewuzie N; Taylor D
    J Psychopharmacol; 2006 Jan; 20(1):86-90. PubMed ID: 16174679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary retention with risperidone].
    Siepmann M; Olbrich H
    Psychiatr Prax; 1997 Jul; 24(4):209. PubMed ID: 9340666
    [No Abstract]   [Full Text] [Related]  

  • 17. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone-induced priapism.
    Makesar D; Thome J
    World J Biol Psychiatry; 2007; 8(1):45-7. PubMed ID: 17366350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3 years of clinical experience with risperidone: new therapeutic standards in the management of schizophrenia].
    Nervenarzt; 1996 Oct; 67(10 Suppl Neue Thera):1-4. PubMed ID: 9403092
    [No Abstract]   [Full Text] [Related]  

  • 20. Switching from depot antipsychotics to risperidone: results of a study of chronic schizophrenia. The Schizophrenia Treatment & Assessment Group.
    Desai NM; Huq Z; Martin SD; McDonald G
    Adv Ther; 1999; 16(2):78-88. PubMed ID: 10539380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.